These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
537 related articles for article (PubMed ID: 35530134)
1. Remembering your A, B, C's: Alzheimer's disease and ABCA1. Lewandowski CT; Laham MS; Thatcher GRJ Acta Pharm Sin B; 2022 Mar; 12(3):995-1018. PubMed ID: 35530134 [TBL] [Abstract][Full Text] [Related]
2. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting. Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483 [TBL] [Abstract][Full Text] [Related]
3. Discovery of Nonlipogenic ABCA1 Inducing Compounds with Potential in Alzheimer's Disease and Type 2 Diabetes. Ben Aissa M; Lewandowski CT; Ratia KM; Lee SH; Layden BT; LaDu MJ; Thatcher GRJ ACS Pharmacol Transl Sci; 2021 Feb; 4(1):143-154. PubMed ID: 33615168 [TBL] [Abstract][Full Text] [Related]
4. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells. DiBlasio-Smith EA; Arai M; Quinet EM; Evans MJ; Kornaga T; Basso MD; Chen L; Feingold I; Halpern AR; Liu QY; Nambi P; Savio D; Wang S; Mounts WM; Isler JA; Slager AM; Burczynski ME; Dorner AJ; LaVallie ER J Transl Med; 2008 Oct; 6():59. PubMed ID: 18925943 [TBL] [Abstract][Full Text] [Related]
5. Small molecule inducers of ABCA1 and apoE that act through indirect activation of the LXR pathway. Fan J; Zhao RQ; Parro C; Zhao W; Chou HY; Robert J; Deeb TZ; Raynoschek C; Barichievy S; Engkvist O; Maresca M; Hicks R; Meuller J; Moss SJ; Brandon NJ; Wood MW; Kulic I; Wellington CL J Lipid Res; 2018 May; 59(5):830-842. PubMed ID: 29563219 [TBL] [Abstract][Full Text] [Related]
6. Identification of a Chrysanthemic Ester as an Apolipoprotein E Inducer in Astrocytes. Fan J; Zareyan S; Zhao W; Shimizu Y; Pfeifer TA; Tak JH; Isman MB; Van den Hoven B; Duggan ME; Wood MW; Wellington CL; Kulic I PLoS One; 2016; 11(9):e0162384. PubMed ID: 27598782 [TBL] [Abstract][Full Text] [Related]
7. The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration. Koldamova R; Fitz NF; Lefterov I Biochim Biophys Acta; 2010 Aug; 1801(8):824-30. PubMed ID: 20188211 [TBL] [Abstract][Full Text] [Related]
8. Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells. Trasino SE; Kim YS; Wang TT Mol Cancer Ther; 2009 Jul; 8(7):1934-45. PubMed ID: 19531574 [TBL] [Abstract][Full Text] [Related]
9. Metabolomic analysis of a selective ABCA1 inducer in obesogenic challenge provides a rationale for therapeutic development. Lewandowski CT; Khan MW; BenAissa M; Dubrovskyi O; Ackerman-Berrier M; LaDu MJ; Layden BT; Thatcher GRJ EBioMedicine; 2021 Apr; 66():103287. PubMed ID: 33752129 [TBL] [Abstract][Full Text] [Related]
10. Development of Tetrachlorophthalimides as Liver X Receptor β (LXRβ)-Selective Agonists. Nomura S; Endo-Umeda K; Makishima M; Hashimoto Y; Ishikawa M ChemMedChem; 2016 Oct; 11(20):2347-2360. PubMed ID: 27690261 [TBL] [Abstract][Full Text] [Related]
11. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice. Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841 [TBL] [Abstract][Full Text] [Related]
12. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells. Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381 [TBL] [Abstract][Full Text] [Related]
13. 5-HT3 Antagonist Ondansetron Increases apoE Secretion by Modulating the LXR-ABCA1 Pathway. Shinohara M; Shinohara M; Zhao J; Fu Y; Liu CC; Kanekiyo T; Bu G Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30934555 [TBL] [Abstract][Full Text] [Related]
14. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride. Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998 [TBL] [Abstract][Full Text] [Related]
15. Direct intracerebral delivery of a miR-33 antisense oligonucleotide into mouse brain increases brain ABCA1 expression. [Corrected]. Jan A; Karasinska JM; Kang MH; de Haan W; Ruddle P; Kaur A; Connolly C; Leavitt BR; Sorensen PH; Hayden MR Neurosci Lett; 2015 Jun; 598():66-72. PubMed ID: 25957561 [TBL] [Abstract][Full Text] [Related]
17. Liver X receptor beta (LXRbeta) interacts directly with ATP-binding cassette A1 (ABCA1) to promote high density lipoprotein formation during acute cholesterol accumulation. Hozoji-Inada M; Munehira Y; Nagao K; Kioka N; Ueda K J Biol Chem; 2011 Jun; 286(22):20117-24. PubMed ID: 21507939 [TBL] [Abstract][Full Text] [Related]
18. Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice. Carter AY; Letronne F; Fitz NF; Mounier A; Wolfe CM; Nam KN; Reeves VL; Kamboh H; Lefterov I; Koldamova R PLoS One; 2017; 12(2):e0172161. PubMed ID: 28241068 [TBL] [Abstract][Full Text] [Related]
19. microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain. Kim J; Yoon H; Horie T; Burchett JM; Restivo JL; Rotllan N; Ramírez CM; Verghese PB; Ihara M; Hoe HS; Esau C; Fernández-Hernando C; Holtzman DM; Cirrito JR; Ono K; Kim J J Neurosci; 2015 Nov; 35(44):14717-26. PubMed ID: 26538644 [TBL] [Abstract][Full Text] [Related]
20. Dynamic changes of Apo A1 mediated by LXR/RXR/ABCA1 pathway in brains of the aging rats with cerebral hypoperfusion. Wang L; Zhang X; Lü Y; Tian M; Li Y Brain Res Bull; 2014 Jan; 100():84-92. PubMed ID: 24291698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]